Results 181 to 190 of about 461,308 (260)

Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells [PDF]

open access: yes, 2019
Abou-Ezzi, Grazia   +17 more
core   +1 more source

Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.

open access: yesJournal of Clinical Oncology, 2014
R. Bejar   +17 more
semanticscholar   +1 more source

Prolonged Hematogone Expansion Is Associated with Better Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. [PDF]

open access: yesHematol Rep
Serio B   +19 more
europepmc   +1 more source

Biotechnical Multiscale Engineering of Scaffolds for Stem Cell and Organoid Research

open access: yesSmall, EarlyView.
Biotechnical multiscale engineering consideration of geometric and structural parameters, which is called biotechnical multiscale engineering, has an influence on stem cell development and organogenesis comparable to that of molecular genetics and biochemical parameters.
Merle‐Johanna Küstner   +13 more
wiley   +1 more source

Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome*

open access: yesCritical Care Medicine, 2017
P. Wohlfarth   +18 more
semanticscholar   +1 more source

Sustained‐Release Sitagliptin Microneedles for Scar Prevention via Fibroblast‐to‐Adipocyte Conversion

open access: yesSmall Science, EarlyView.
The authors propose a novel use for the conventional hypoglycemic drug, dipeptidyl peptidase IV (DPP4+) inhibitor sitagliptin. Sitagliptin prevents scar formation during wound healing through fibroblast‐to‐adipocyte conversion at least by preventing DPP4‐mediated truncation of IGF‐1.
Ju‐Lei Zhang   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy